Boston Scientific To Pay $296M To Settle Probe
Boston Scientific Corp. subsidiary Guidant Corp. will plead guilty to two misdemeanor charges and pay $296 million to end a U.S. Department of Justice probe into cardiac defibrillator product advisories it...To view the full article, register now.
Already a subscriber? Click here to view full article